Point-of-care management of urogenital Chlamydia trachomatis via Gram stained smear analysis in male high-risk patients. Diagnostic accuracy and cost effectiveness before and after changing the screening indication at the STI Clinic in Amsterdam.

To measure the effect of changing the point-of-care (POC) testing algorithm of urogenital chlamydia for all male high-risk patients to those with only symptoms with respect to: diagnostic accuracy, loss to follow-up, correctly managed consultations and costs.